Title: High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis

Similar documents
Augmented Renal Clearance: Let s Get the Discussion Flowing

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation

Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients

The estimation of kidney function with different formulas in overall population

GFR and Drug Dosage Adaptation: Are We still in the Mist?

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!

Augmented renal clearance in Japanese intensive care unit patients: a prospective study

Measurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE

Validity of the use of Schwartz formula against creatinine clearance in the assessment of renal functions in children

Measurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE

9. GFR - WHERE ARE WE NOW?

Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?

Renal function vs chemotherapy dosing

Can modifications of the MDRD formula improve the estimation of glomerular filtration rate in renal allograft recipients?

Antibiotics requiring dosage adjustment in community acquired pneumonia patients with renal impairment

Acute renal failure Definition and detection

Validation of El-Minia Equation for Estimation of Glomerular Filtration Rate in Different Stages of Chronic Kidney Disease

2017/3/7. Evaluation of GFR. Chronic Kidney Disease (CKD) Serum creatinine(scr) Learning Objectives

Measure Abbreviation: AKI 01 (QCDR Measure ID: ASPIRE19)

Review Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC

Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31

Life Science Journal 2014;11(10)

Assessing Renal Function: What you Didn t Know You Didn t Know

Carboplatin Time to Drop the Curtain on the Dosing Debate

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control

Title: Evaluation of the Housing First Program in patients with severe mental disorders in France: study protocol for a randomised controlled trial

Glomerular Filtration Rate Estimations and Measurements. Pierre Delanaye, MD, PhD University of Liège CHU Sart Tilman BELGIUM

BACKGROUND Measuring renal function :

Sebastião Rodrigues Ferreira-Filho, Camila Caetano Cardoso, Luiz Augusto Vieira de Castro, Ricardo Mendes Oliveira, and Renata Rodrigues Sá

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine

Udy et al. BMC Nephrology 2013, 14:250

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Renal Function and Associated Laboratory Tests

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS

Modifying Drug Dosing for Patients with Renal Insufficiency

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro

GFR Estimation in Adolescents and Young Adults

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist

Special Challenges and Co-Morbidities

Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary -trace protein

AUGMENTED RENAL CLEARANCE and its clinical implications. Professor Jeffrey Lipman

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults

Comparison of Modified Jaffe s Kinetic Method and Enzymatic Method of Serum Creatinine Estimation for Precision, Linearity and Effect of Interferent

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης

RENAL FUNCTION ASSESSMENT ASSESSMENT OF GLOMERULAR FUNCTION ASSESSMENT OF TUBULAR FUNCTION

International Journal of Medical and Health Sciences

Environmental Variability

ECN Protocol Book. Generic Chemotherapy Protocol Guidelines. ECN_Protocol_Book_generic chemotherapy protocol guidelines guidelines_1

Title:Impaired renal function and associated risk factors in newly diagnosed HIV-infected Adults in Gulu Hospital, Northern Uganda

Correspondence should be addressed to Maisarah Jalalonmuhali;

GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease

Cystatin C: A New Approach to Improve Medication Dosing

WEEK. MPharm Programme. Acute Kidney Injury. Alan M. Green MPHM13: Acute Kidney Injury. Slide 1 of 47

Title: Who does not participate in a follow-up postal study? A survey of infertile couples treated by in vitro fertilization

Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patients

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patients

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

The Rate of Antibiotic Dosage Adjustment in Renal Dysfunction

Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

Update on HIV-Related Kidney Diseases. Agenda

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Prediction of two-sample 99m Tc-diethylene triamine pentaacetic acid plasma clearance from single-sample method

Title: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy

REVISITING THE PHARMACOKINETICS IN PATIENTS

Public Assessment Report. EU worksharing project paediatric data. Valcyte. Valganciclovir

Author's response to reviews

Optimizing Antibiotic Therapy in the ICU For Pneumonia Current and Future Approaches

Adult Institutional Pharmacokinetics Protocol

Author's response to reviews

Case Studies: Renal and Urologic Impairments Workshop

Title: Defensive coping and health-related quality of life in Chronic Kidney Disease: a cross-sectional study

Title: A Prospective Study of Dietary Selenium Intake and Risk of Type 2 Diabetes

Author's response to reviews

Citation for published version (APA): Sinkeler, S. J. (2016). A tubulo-centric view on cardiorenal disease. [Groningen].

Monica Edholm Medica Medic l a Pr oducts Agency

MDRD vs. CKD-EPI in comparison to

Characteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests

Chronic Kidney Disease Prevalence and Rate of Diagnosis

Comparison of Estimated Glomerular Filtration Rate Using Different Analytes in Chronic Kidney Disease Patients

Foo Koon Mian Pharmacy Resident National University of Singapore Hematology / Oncology Pharmacy Residency Program. 4th APOPC November 2012

Creatinine-based equations for the adjustment of drug dosage in an obese population

Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipients

Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function.

How and why to measure renal function in patients with liver disease?

Title: Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals

Acute kidney injury and outcomes in acute decompensated heart failure in Korea

Performance of MDRD study and CKD-EPI equations for long-term follow-up of nondiabetic patients with chronic kidney disease

Brief Report. Introduction

Have you seen a patient like Elaine *?

FRCPath Part 1 written examination in Clinical Biochemistry

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW:

Clinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)

Title: Dengue Score: a proposed diagnostic predictor of pleural effusion and/or ascites in adult with dengue infection

ORIGINAL ARTICLE Estimating the glomerular filtration rate using serum cystatin C levels in patients with spinal cord injuries

ASSESSMENT OF A POINT-OF-CARE DEVICE FOR MEASURING CREATININE IN A COMMUNITY SCREENING PROGRAM FOR CHRONIC KIDNEY DISEASE

Transcription:

Author's response to reviews Title: High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis Authors: Alexandre Lautrette (alautrette@chu-clermontferrand.fr) Thuy-Nga Phan (thuy-nga.phan@chu-lyon.fr) Lemlih Ouchchane (Lemlih.OUCHCHANE@u-clermont1.Fr) Ali AitHssain (aait_hssain@chu-clermontferrand.fr) Vincent Tixier (vtixier@chu-clermontferrand.fr) Anne-Elisabeth Heng (aheng@chu-clermontferrand.fr) Bertrand Souweine (bsouweine@chu-clermontferrand.fr) Version: 4 Date: 4 September 2012 Author's response to reviews: see over

The Editor in Chief BMC Nephrology Department of ICU and Nephrology Gabriel Montpied Teaching Hospital 54 rue Montalembert BP69 63003 Clermont Ferrand Cedex 1 FRANCE Tuesday, September 4, 2012 Dear Sir, Please find enclosed the revised version of the BMC Nephrology manuscript 1323310638740034 entitled High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis. We would like to thank the reviewers for their help in improving our manuscript. All the comments and suggestions have been taken into account and we have included pointby-point replies to the reviewers remarks. As the corresponding author, I remain at your disposal for any further information. Sincerely yours, Dr A Lautrette 1

We are grateful to the Reviewers for making constructive comments that have helped us to improve our manuscript. Replies to Reviewer Andrew Udy Thank-you for the opportunity to review this interesting work by Lautrette and colleagues. This report adds to the weight of growing literature describing the prevalence of augmented renal clearance (ARC) in subsets of critically ill patients. The data should be of interest to a wide variety of clinicians, least of which include infectious disease specialists and intensive care physicians. The clinical imperative to optimize antibacterial dosing in this group of patients is well established, although very limited conclusions can be drawn in reference to clinical outcomes and pharmacokinetic end-points from the data provided. Despite this, there appears to be a very clear signal that such patients are likely to manifest ARC, clearly warranting further investigation. Major Compulsory Revisions: 1) Can the authors provide clarification on how they have dealt with repeated measures in their analysis? Specifically, it is noted that a significant number of patients did not remain in the ICU for the full 7 days, suggesting that individual patients may have contributed differing numbers of measured creatinine clearances (CLCR) / mathematically derived estimates? We agree. If we take into account only one value per patient - the lowest measured creatinine clearances in patients with high CrCl, and the highest in patients without high CrCl - the best threshold for the Cockcroft-Gault formula to predict high CrCl is 101ml/min/1.73m² (sensitivity: 0.93, specificity: 0.82, AUC = 0.92±0.05), similar to the threshold reported in the original manuscript (101ml/min/1.73m² with sensitivity: 0.96, specificity: 0.75, AUC = 2

0.90±0.03). For the simplified MDRD equation, the best threshold was 103ml/min/1.73m² (sensitivity: 0.93, specificity: 0.77, AUC = 0.91±0.06) instead of 108ml/min/1.73m² (sensitivity: 0.91, specificity: 0.80, AUC = 0.88±0.03) in the original manuscript. The difference between these two thresholds is not clinically significant for a screening tool. 2) Is it appropriate to treat each measure as an independent event? This approach should be stated in the manuscript. See reply above. We treated each measure as an independent event. This point has been included in the Methods section (Statistical analysis): Each measure was treated as an independent event. 3) How was the patients height and weight measured (for calculation of BSA)? The patients height and weight were measured in a supine position on ICU admission with a tape measure and a Hill Rom bed (Medicraft, Marrickville NSW, Australia), respectively. This point is mentioned in the Methods section. 4) It is not clear at what time point (eg at ICU admission or at any subsequent point) some of the therapeutic variables were recorded. Eg. the requirement for mechanical ventilation? or Vasopressors? This point has been taken into account. In table 1, the data are presented with the time point at which they were recorded (on admission or during ICU stay). 3

5) Bland-Altman analysis is a key technique for the interpretation of diagnostic accuracy / tests. The details of this approach should be provided in the statistical analysis section, prior to reporting the results thereof later in the manuscript. We have added the sentence in Methods section (Statistical analysis): For comparisons between measurement methods, we built a Bland-Altman plot between differences and averages seeking possible biases and outliers. 6) Can the authors expand on why they have chosen a threshold value of > 140ml/min/1.73m2? The relevant literature would suggest a cut-off value of > 130ml/min/1.73m2 being associated with sub-therapeutic antibacterial drug concentrations? We agree with reviewer. However, there is no consensual definition of augmented renal clearance in the literature. Among the major papers in this field, three used a cut-off value > 130ml/min/1.73m² ((i) Baptista, Critical Care, 2011; (ii) Udy, Chest, 2011 and (iii) Baptista, Int J Antimicrob Agents 2012) and three others used thresholds >120 ml/min/1.73m² (Fuster- Lluch, Anaesth Intensive Care, 2008 and Minville, Critical Care, 2011); > 150 ml/min/1.73m² in females and > 160 ml/min/1.73m² in males (Udy, Anesth Analg, 2010). The high cut-off value used in our study leads to increased specificity in the diagnosis of augmented renal clearance. Minor Essential Revisions: Abstract, Results section Line 5 - suggest to change to "..with a negative likelihood ratio of 0.06." 4

Line 6/7 - suggest to change to ".. with a negative likelihood ratio of 0.11" Abstract, Conclusions section Recommend changing this to suggest that the mathematical formulae may be useful as a "screening" tool to identify high ClCr. A surrogate would suggest it can be used in place of, which given the lack of accuracy of these estimates at higher ClCr, is not the case. We have rephrased the sentence: The estimated methods of CrCl could be used as a screening tool to identify high ClCr. Background section, 2nd paragraph, line 2 - "postoperatives" is not a word. Suggest change to " in the post-operative setting" or similar Results section, 1st paragraph, line 4 - suggest change "fungi" to "fungal" Discussion section, 1st paragraph, line 2 - suggest using the term "screened for" rather than predicted (see earlier comments), given that the authors focus on a lower limit value, below which ARC is going to be unlikely. Discussion section, 3rd paragraph, line 21 - suggest using "screening tool" rather than "surrogate" (see earlier comments) We have rephrased the sentence: Our findings are in agreement with previously published data and suggest that the estimated methods of CrCl could be used as a screening tool to diagnose high ClCr with a 101 ml/min/1.73m² threshold for Cockcroft-Gault formula and a 108 ml/min/1.73m² threshold for simplified MDRD equation. 5

Replies to Reviewer Jean-Philippe Haymann A Lautrette et al report in their work the high incidence of hyperfiltration in a series of 32 patients hospitalized for meningitis within the seven first day of ICU admission. They furthermore assess threshold value for cockcroft and MDRD equations to assess hyperfiltration in a daily practice. To my view, the authors have adequately answer previous reviewers concerns. There is however mainly two limitations in this study : 1) the measurement of creatinine clearance that do not allow a discrimination between a high GFR and/or tubular creatinine secretion We agree with the reviewer. Tubular secretion of creatinine increases with decreasing GFR (G Vervoort et al.: Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new MDRD prediction equation. Nephrol Dial Transplant (2002) 17: 1909 1913). As shown in Figure 1 of this article, when GFR is high, tubular creatinine secretion is very low. Thus, this suggests that the augmented creatinine clearance observed in our patients is related to augmented GFR rather than to augmented tubular creatinine secretion. 2) The creatinine measurement using the Jaffe method instead of enzymatic method We agree with the reviewer. Between January 2006 and December 2009, the biochemistry laboratory of our hospital used the compensated Jaffe method (we have added this point in the Methods section) to measure creatinine, like 80% of biochemistry laboratories in France (French report of the Haute Autorité de Santé on Évaluation du débit de filtration glomérulaire, et du dosage de la créatininémie dans le diagnostic de la maladie rénale chronique chez l adulte, December 2011). The enzymatic method is more accurate in 6

measuring creatinine than the Jaffe method. However, the error of measurement with the compensated Jaffe method is lower than 2µmol/L when serum creatinine is < 76µmol/L ( (i) Delanghe JR et al.: Trueness verification of actual creatinine assays in the European market demonstrates a disappointing variability that needs substantial improvement. An international study in the framework of the EC4 creatinine standardization working group. Clin Chem Lab Med 2008; 46(9):1319-25; (ii) Miller WG et al.: Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med 2005; 129(3):297-304). We think that the error in creatinine measurement with the compensated Jaffe method did not have any impact on our results. Despite these limitations, these findings lay the stress on the requirement to adapt the posology of some antibiotics in these circumstances. Discretionary Revisions: As serum creatinine was performed using a Jaffe method, 24 hours creatinine clearance is underestimated compared to enzymatic creatinine method. It would be however interesting to have an idea of the magnitude of (24 hours) creatinine clearance increase: what is the mean percentage of creatinine clearance increase in the population experiencing hyperfiltration (ratio between Clcr max and ClCr at discharge)? A ratio above 100% would suggest a very likely tubular secretion at play (in part...). As the reviewer suggested we determined the ratio between CrCl max and CrCl at discharge in 14 of 15 patients with high CrCl during the first 7 days in the ICU (one patient had renal failure requiring dialysis at ICU discharge). All patients had a ratio above 100%. The mean 7

ratio was 183% +/- 58. We do not know if this can be considered as a strong argument for tubular secretion. 8